Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
47.17
Dollar change
+0.26
Percentage change
0.55
%
IndexRUT P/E- EPS (ttm)-3.38 Insider Own45.35% Shs Outstand24.36M Perf Week1.18%
Market Cap1.40B Forward P/E- EPS next Y-5.09 Insider Trans0.79% Shs Float16.21M Perf Month20.55%
Income-80.60M PEG- EPS next Q-1.10 Inst Own51.09% Short Float9.72% Perf Quarter47.22%
Sales0.00M P/S- EPS this Y-38.99% Inst Trans3.39% Short Ratio3.89 Perf Half Y-26.18%
Book/sh13.69 P/B3.45 EPS next Y-7.06% ROA-26.96% Short Interest1.58M Perf Year-0.72%
Cash/sh11.55 P/C4.08 EPS next 5Y- ROE-28.23% 52W Range25.60 - 77.60 Perf YTD-18.33%
Dividend Est.- P/FCF- EPS past 5Y- ROI-23.75% 52W High-39.21% Beta0.57
Dividend TTM- Quick Ratio23.70 Sales past 5Y0.00% Gross Margin- 52W Low84.26% ATR (14)2.57
Dividend Ex-Date- Current Ratio23.70 EPS Y/Y TTM29.92% Oper. Margin0.00% RSI (14)61.25 Volatility4.64% 6.60%
Employees74 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.33 Target Price64.33
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q9.62% Payout- Rel Volume0.61 Prev Close46.91
Sales Surprise- EPS Surprise-8.11% Sales Q/Q- EarningsMay 09 BMO Avg Volume404.97K Price47.17
SMA206.39% SMA5025.56% SMA200-4.96% Trades Volume245,708 Change0.55%
Date Action Analyst Rating Change Price Target Change
Apr-01-24Downgrade Raymond James Strong Buy → Outperform $40
Dec-19-23Downgrade Morgan Stanley Overweight → Equal-Weight $56 → $65
Jun-09-23Upgrade Raymond James Outperform → Strong Buy $50 → $75
Jun-07-23Initiated H.C. Wainwright Buy $55
May-17-23Initiated Raymond James Outperform $50
Apr-28-23Initiated Cantor Fitzgerald Overweight $45
Apr-21-23Initiated Stifel Buy $37
Apr-20-23Initiated Morgan Stanley Overweight $37
Mar-23-23Initiated BMO Capital Markets Outperform $40
Feb-28-23Initiated SVB Securities Outperform $36
Jun-28-24 08:11PM
Jun-14-24 08:03AM
07:30AM
May-30-24 09:00AM
May-14-24 10:30AM
08:00AM Loading…
May-13-24 08:00AM
May-11-24 05:31AM
May-09-24 01:54PM
08:00AM
Apr-02-24 02:24PM
Apr-01-24 04:19PM
08:00AM
Mar-23-24 05:31AM
Mar-21-24 08:00AM
Mar-06-24 04:30PM
08:30AM Loading…
Feb-26-24 08:30AM
Feb-20-24 08:30AM
Feb-09-24 09:00AM
Feb-07-24 08:00AM
Jan-03-24 05:00PM
Dec-22-23 06:35PM
Dec-20-23 04:30PM
Dec-15-23 03:01PM
Dec-11-23 08:30PM
12:00PM
Dec-08-23 07:06AM
Nov-14-23 04:44PM
Nov-13-23 09:55AM
Nov-09-23 09:34AM
08:30AM
04:30PM Loading…
Nov-08-23 04:30PM
Nov-02-23 09:00AM
Oct-23-23 09:15AM
Oct-03-23 08:30AM
Sep-20-23 04:30PM
Aug-30-23 04:15PM
Aug-24-23 11:20AM
Aug-11-23 08:50AM
08:00AM
Jul-27-23 09:00AM
Jul-25-23 09:55AM
Jun-22-23 04:15PM
Jun-20-23 07:33PM
Jun-13-23 10:39PM
Jun-12-23 04:00PM
01:59AM
Jun-09-23 04:13PM
07:00AM
Jun-01-23 03:10PM
May-31-23 04:00PM
May-15-23 07:00AM
May-11-23 10:15AM
May-10-23 10:23AM
May-05-23 08:50AM
May-04-23 12:00PM
Apr-28-23 05:00AM
Apr-27-23 08:05AM
Apr-21-23 08:30AM
Apr-19-23 08:50AM
Apr-13-23 11:00AM
Mar-31-23 07:00AM
Mar-30-23 07:05AM
Mar-21-23 07:00AM
Feb-16-23 08:00AM
Feb-14-23 06:30AM
Feb-08-23 04:00PM
Jan-20-23 07:00AM
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. The company was founded in October 2017 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Quisel John DChief Executive OfficerJul 08 '24Option Exercise1.013,0003,03072,065Jul 10 04:15 PM
White William RichardDirectorJul 01 '24Option Exercise9.862011,982201Jul 03 04:15 PM
White William RichardDirectorJul 01 '24Sale46.042019,2530Jul 03 04:15 PM
Bitterman KevinDirectorJun 17 '24Buy36.00222,2238,000,028420,549Jun 20 08:00 PM
Ashiya MonaDirectorJun 17 '24Buy36.0083,3343,000,024941,569Jun 20 05:27 PM
ORBIMED ADVISORS LLCDirectorJun 17 '24Buy36.0083,3343,000,024941,569Jun 20 05:19 PM
White William RichardDirectorJun 03 '24Option Exercise3.391,9576,6351,957Jun 05 04:05 PM
White William RichardDirectorJun 03 '24Sale36.081,95770,6080Jun 05 04:05 PM
White William RichardDirectorMay 01 '24Option Exercise9.862011,982201May 03 04:05 PM
White William RichardDirectorMay 01 '24Sale28.632015,7550May 03 04:05 PM
White William RichardDirectorApr 11 '24Option Exercise4.912,56012,5812,560Apr 15 06:27 PM
White William RichardDirectorApr 11 '24Sale31.802,56081,4070Apr 15 06:27 PM
Savage William JacobChief Medical OfficerApr 10 '24Option Exercise2.6521,87057,95643,405Apr 11 05:02 PM
Bitterman KevinDirectorMar 05 '24Sale73.5026,1571,922,540677,503Mar 07 04:40 PM
Bitterman KevinDirectorJan 23 '24Sale67.65102,5006,934,125198,326Jan 25 04:33 PM
Atlas Venture Fund X, L.P.10% OwnerJan 23 '24Sale67.65102,5006,934,125198,326Jan 25 04:31 PM
Atlas Venture Fund X, L.P.10% OwnerJan 23 '24Sale67.6547,5003,213,3751,402,186Jan 25 04:31 PM
Atlas Venture Fund X, L.P.10% OwnerJan 10 '24Sale64.0030,0001,920,0001,449,686Jan 12 05:12 PM
Bitterman KevinDirectorJan 10 '24Sale64.0020,0001,280,000786,160Jan 12 05:12 PM
Atlas Venture Fund X, L.P.10% OwnerJan 10 '24Sale64.0020,0001,280,000786,160Jan 12 05:12 PM
Quisel John DChief Executive OfficerDec 29 '23Option Exercise1.012,7002,7272,700Jan 03 04:05 PM
Bryce JoanneChief Financial OfficerDec 27 '23Option Exercise9.863,00029,5805,500Dec 29 04:15 PM
Ashiya MonaDirectorDec 18 '23Option Exercise38.001,72465,5121,724Dec 20 06:16 PM
ORBIMED ADVISORS LLCDirectorDec 18 '23Option Exercise38.001,72465,5121,724Dec 20 06:28 PM
Ashiya MonaDirectorDec 18 '23Sale59.241,724102,1300Dec 20 06:16 PM
ORBIMED ADVISORS LLCDirectorDec 18 '23Sale59.241,724102,1300Dec 20 06:28 PM
ORBIMED ADVISORS LLCDirectorDec 14 '23Sale56.75433,20024,584,100224,405Dec 15 06:04 PM
Ashiya MonaDirectorDec 14 '23Sale56.75433,20024,584,100224,405Dec 15 06:09 PM
Atlas Venture Fund X, L.P.10% OwnerDec 14 '23Sale58.2830,8251,796,4371,479,686Dec 14 08:13 PM
Bitterman KevinDirectorDec 14 '23Sale58.2820,5491,197,567806,160Dec 14 08:14 PM
Atlas Venture Fund X, L.P.10% OwnerDec 14 '23Sale58.2820,5491,197,567806,160Dec 14 08:13 PM
Ashiya MonaDirectorDec 14 '23Sale57.7320011,546727,807Dec 14 05:40 PM
ORBIMED ADVISORS LLCDirectorDec 14 '23Sale57.7320011,546727,807Dec 14 05:44 PM
ORBIMED ADVISORS LLCDirectorDec 13 '23Sale58.56106,7006,248,352281,505Dec 14 05:44 PM
Ashiya MonaDirectorDec 13 '23Sale58.56106,7006,248,352281,505Dec 14 05:40 PM
Atlas Venture Fund X, L.P.10% OwnerDec 13 '23Sale60.005,323319,3571,510,511Dec 14 08:13 PM
Atlas Venture Fund X, L.P.10% OwnerDec 13 '23Sale60.003,548212,865826,709Dec 14 08:13 PM
Bitterman KevinDirectorDec 13 '23Sale60.003,548212,865826,709Dec 14 08:14 PM
White William RichardDirectorDec 12 '23Option Exercise6.0833,511203,88333,511Dec 14 04:15 PM
Bryce JoanneChief Financial OfficerDec 12 '23Option Exercise2.652,5006,6255,000Dec 14 04:15 PM
Atlas Venture Fund X, L.P.10% OwnerDec 12 '23Sale62.8077,9514,895,0321,515,834Dec 14 08:13 PM
Bitterman KevinDirectorDec 12 '23Sale62.8051,9673,263,328830,257Dec 14 08:14 PM
Atlas Venture Fund X, L.P.10% OwnerDec 12 '23Sale62.8051,9673,263,328830,257Dec 14 08:13 PM
White William RichardDirectorDec 12 '23Sale63.2133,5112,118,2390Dec 14 04:15 PM
Ashiya MonaDirectorDec 12 '23Sale60.1627,3001,642,368295,605Dec 14 05:40 PM
ORBIMED ADVISORS LLCDirectorDec 12 '23Sale60.1627,3001,642,368295,605Dec 14 05:44 PM
Bryce JoanneChief Financial OfficerDec 12 '23Sale65.222,500163,0622,500Dec 14 04:15 PM
Bryce JoanneChief Financial OfficerDec 05 '23Option Exercise1.011,2811,2945,041Dec 07 04:15 PM
Bryce JoanneChief Financial OfficerDec 05 '23Sale56.002,541142,2992,500Dec 07 04:15 PM
Khara RahulGeneral CounselNov 22 '23Option Exercise14.6910,000146,90010,000Nov 27 04:15 PM
Khara RahulGeneral CounselNov 22 '23Sale51.7310,000517,3330Nov 27 04:15 PM
Khara RahulGeneral CounselNov 14 '23Option Exercise14.694,90071,9814,900Nov 15 05:00 PM
Khara RahulGeneral CounselNov 14 '23Sale50.614,900248,0120Nov 15 05:00 PM
Khara RahulGeneral CounselNov 03 '23Option Exercise14.691001,469100Nov 07 06:22 PM
Khara RahulGeneral CounselNov 03 '23Sale50.001005,0000Nov 07 06:22 PM
Atlas Venture Fund X, L.P.10% OwnerSep 16 '23Sale53.222,115112,5601,593,785Sep 18 04:59 PM
Atlas Venture Fund X, L.P.10% OwnerSep 15 '23Sale53.16260,89413,869,1251,595,900Sep 18 04:59 PM
Atlas Venture Fund X, L.P.10% OwnerSep 14 '23Sale53.0594,4405,010,0421,856,794Sep 18 04:59 PM
Bryce JoanneChief Financial OfficerSep 11 '23Option Exercise9.862,50024,6503,760Sep 13 04:15 PM
Bryce JoanneChief Financial OfficerSep 01 '23Option Exercise2.651,0002,6502,260Sep 05 04:16 PM
Bryce JoanneChief Financial OfficerSep 01 '23Sale52.991,00052,9901,260Sep 05 04:16 PM
Savage William JacobChief Medical OfficerAug 21 '23Option Exercise2.653,0007,9503,000Aug 22 04:06 PM
Atlas Venture Fund X, L.P.10% OwnerAug 15 '23Sale52.40111,0695,820,0161,951,234Aug 16 06:55 PM
Bitterman KevinDirectorAug 15 '23Sale52.4072,9313,821,584882,224Aug 17 04:13 PM
Atlas Venture Fund X, L.P.10% OwnerAug 15 '23Sale52.4072,9313,821,584882,224Aug 16 06:55 PM
Savage William JacobChief Medical OfficerAug 15 '23Sale52.957,672406,2350Aug 16 04:15 PM
Atlas Venture Fund X, L.P.10% OwnerAug 14 '23Sale52.59175,0009,203,6002,062,303Aug 16 06:55 PM
Savage William JacobChief Medical OfficerAug 09 '23Sale49.838,269412,0647,672Aug 11 04:15 PM
Bryce JoanneChief Financial OfficerAug 01 '23Option Exercise1.014,5214,5665,781Aug 03 04:18 PM
Bryce JoanneChief Financial OfficerAug 01 '23Sale49.914,521225,6331,260Aug 03 04:18 PM